YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity. Issue 41 (11th October 2018)
- Record Type:
- Journal Article
- Title:
- YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity. Issue 41 (11th October 2018)
- Main Title:
- YAP and MRTF-A, transcriptional co-activators of RhoA-mediated gene expression, are critical for glioblastoma tumorigenicity
- Authors:
- Yu, Olivia
Benitez, Jorge
Plouffe, Steven
Ryback, Daniel
Klein, Andrea
Smith, Jeff
Greenbaum, Jason
Delatte, Benjamin
Rao, Anjana
Guan, Kun-Liang
Furnari, Frank
Chaim, Olga
Miyamoto, Shigeki
Brown, Joan - Abstract:
- Abstract The role of YAP (Yes-associated protein 1) and MRTF-A (myocardin-related transcription factor A), two transcriptional co-activators regulated downstream of GPCRs (G protein-coupled receptors) and RhoA, in the growth of glioblastoma cells and in vivo glioblastoma multiforme (GBM) tumor development was explored using human glioblastoma cell lines and tumor-initiating cells derived from patient-derived xenografts (PDX). Knockdown of these co-activators in GSC-23 PDX cells using short hairpin RNA significantly attenuated in vitro self-renewal capability assessed by limiting dilution, oncogene expression, and neurosphere formation. Orthotopic xenografts of the MRTF-A and YAP knockdown PDX cells formed significantly smaller tumors and were of lower morbidity than wild-type cells. In vitro studies used PDX and 1321N1 glioblastoma cells to examine functional responses to sphingosine 1-phosphate (S1P), a GPCR agonist that activates RhoA signaling, demonstrated that YAP signaling was required for cell migration and invasion, whereas MRTF-A was required for cell adhesion; both YAP and MRTF-A were required for proliferation. Gene expression analysis by RNA-sequencing of S1P-treated MRTF-A or YAP knockout cells identified 44 genes that were induced through RhoA and highly dependent on YAP, MRTF-A, or both. Knockdown ofF3 (tissue factor (TF)), a target gene regulated selectively through YAP, blocked cell invasion and migration, whereas knockdown ofHBEGF (heparin-binding epidermalAbstract The role of YAP (Yes-associated protein 1) and MRTF-A (myocardin-related transcription factor A), two transcriptional co-activators regulated downstream of GPCRs (G protein-coupled receptors) and RhoA, in the growth of glioblastoma cells and in vivo glioblastoma multiforme (GBM) tumor development was explored using human glioblastoma cell lines and tumor-initiating cells derived from patient-derived xenografts (PDX). Knockdown of these co-activators in GSC-23 PDX cells using short hairpin RNA significantly attenuated in vitro self-renewal capability assessed by limiting dilution, oncogene expression, and neurosphere formation. Orthotopic xenografts of the MRTF-A and YAP knockdown PDX cells formed significantly smaller tumors and were of lower morbidity than wild-type cells. In vitro studies used PDX and 1321N1 glioblastoma cells to examine functional responses to sphingosine 1-phosphate (S1P), a GPCR agonist that activates RhoA signaling, demonstrated that YAP signaling was required for cell migration and invasion, whereas MRTF-A was required for cell adhesion; both YAP and MRTF-A were required for proliferation. Gene expression analysis by RNA-sequencing of S1P-treated MRTF-A or YAP knockout cells identified 44 genes that were induced through RhoA and highly dependent on YAP, MRTF-A, or both. Knockdown ofF3 (tissue factor (TF)), a target gene regulated selectively through YAP, blocked cell invasion and migration, whereas knockdown ofHBEGF (heparin-binding epidermal growth factor-like growth factor), a gene selectively induced through MRTF-A, prevented cell adhesion in response to S1P. Proliferation was sensitive to knockdown of target genes regulated through either or both YAP and MRTF-A. Expression of TF and HBEGF was also selectively decreased in tumors from PDX cells lacking YAP or MRTF-A, indicating that these transcriptional pathways are regulated in preclinical GBM models and suggesting that their activation through GPCRs and RhoA contributes to growth and maintenance of human GBM. … (more)
- Is Part Of:
- Oncogene. Volume 37:Issue 41(2018)
- Journal:
- Oncogene
- Issue:
- Volume 37:Issue 41(2018)
- Issue Display:
- Volume 37, Issue 41 (2018)
- Year:
- 2018
- Volume:
- 37
- Issue:
- 41
- Issue Sort Value:
- 2018-0037-0041-0000
- Page Start:
- 5492
- Page End:
- 5507
- Publication Date:
- 2018-10-11
- Subjects:
- Oncogenes -- Periodicals
Oncogenes
Oncogenes -- Periodicals
Electronic journals
Periodicals
616.994042 - Journal URLs:
- http://www.nature.com/onc/index.html ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0950-9232;screen=info;ECOIP ↗
http://www.intute.ac.uk/healthandlifesciences/cgi-bin/fullrecord.pl?handle=2013340 ↗
http://www.nature.com/ ↗ - DOI:
- 10.1038/s41388-018-0301-5 ↗
- Languages:
- English
- ISSNs:
- 0950-9232
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6256.782000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11054.xml